Abstract We evaluated the four-dimensional (4D) dose to a moving target by a Monte Carlo dose calculation algorithm in stereotactic body radiation therapy (SBRT) planning based on the isocenter dose prescription. 4D computed tomography scans were performed for 12 consecutive patients who had 14 tumors. The gross tumor volume (GTV) and internal target volume (ITV) were contoured manually, and the planning target volume (PTV) was defined as the ITV with a 5-mm margin. The beam apertures were shaped into the PTV plus a 5-mm leaf margin. The prescription dose was 48 Gy in 4 fractions at the isocenter. The GTV dose was calculated by accumulation of respiratory-phase dose distributions that were mapped to a reference images, whereas the ITV and PTV doses were calculated with the respiration-averaged images. The doses to 99 % (D 99 ) of the GTV, ITV, and PTV were 90.2, 89.3, and 82.0 %, respectively. The mean difference between the PTV D 99 and GTV D 99 was -9.1 % (range -13.4 to -4.0 %), and that between the ITV and GTV was -1.1 % (range -5.5 to 1.9 %). The mean homogeneity index (HI) for the GTV, ITV, and PTV was 1.14, 1.15, and 1.26, respectively. Significant differences were observed in the D 99 and HI between the PTV and GTV, whereas no significant difference was seen between the ITV and GTV. When SBRT planning is performed based on the isocenter dose prescription with a 5-mm PTV margin and a 5-mm leaf margin, the ITV dose provides a good approximation of the GTV dose.
Introduction
Stereotactic body radiation therapy (SBRT) has to be highly conformal to minimize normal-tissue toxicity. Initial results of Phase I trials of SBRT for early stage non-small-cell lung cancer have been highly promising, with excellent rates of local control [1] [2] [3] [4] . One issue in lung SBRT which needs to be addressed is respiratory motion, given that lung tumors move up to 2 cm with respiration [5] . Proposed solutions to lung tumor motion include a motion-encompassing approach that uses a slow computed tomography (CT) scan, inhale and exhale breath-holding CT scan, or maximum-intensity projection (MIP) images from a four-dimensional (4D) CT scan [6] . In clinical practice, the three-dimensional (3D) dose distribution is calculated on these images or on the averaged intensity projection (AIP) images derived from 4D CT, and plan evaluation is performed based on the dose to the planning target volume (PTV) as representative of the tumor dose. For example, the Japan Clinical Oncology Group (JCOG) 0403 protocol, a Phase II study of SBRT for T1N0M0 non-small cell lung cancer, and the JCOG 0702 protocol, a Phase I study of the efficacy and safety of SBRT, adopted the PTV dose to report the tumor dose [7, 8] .
Keall [9] proposed 4D treatment planning by use of deformable image registration (DIR). The DIR calculates the volumetric mapping of 3D CT images in one respiratory phase to another phase. The calculated mappings are used for mapping of dose distributions on each respiratory phase to a reference phase. The 4D dose to the gross tumor volume (GTV) can be estimated by accumulation of the mapped dose distributions. The 4D dose calculation is useful not only for 4D treatment delivery, but also for re-evaluation of the GTV dose that has already been delivered. In the JCOG 0403 and 0702 protocols and other multi-institutional studies for lung SBRT in Japan [10] [11] [12] [13] , which also have shown high control rates and favorable outcomes, the GTV dose has not been reported. If a dose difference between the PTV and GTV exists, the GTV dose cannot be estimated from the PTV dose without 4D dose calculation. For understanding the clinical outcomes and designing a new treatment approach, estimation of the relationships between the GTV and PTV dose, as well as the GTV and internal target volume (ITV) dose, would be important.
Guckenberger et al. [14] reported that the peripheral dose to the PTV significantly underestimated the dose to the GTV. Admiraal et al. [15] also showed the comparability of the GTV and ITV dose. These studies were performed with the peripheral dose prescription methods, such as the dose to cover 95 % of the PTV (D 95 ). The D 95 prescription method was adopted in various clinical trials such as the JCOG 0702 and Radiation Therapy Oncology Group (RTOG) 0236 [16] . In contrast, the JCOG 0403 protocol and the above-mentioned multi-institutional studies adopted the dose prescription at the isocenter, and there are few data about the GTV dose in these studies.
In general, the Monte Carlo dose calculation algorithm has proved to be the most accurate dose-modeling approach [17] [18] [19] [20] . Several authors have investigated dose differences between the pencil-beam and the Monte Carlo algorithms for lung SBRT, with results showing that the peripheral dose to the PTV predicted by the Monte Carlo algorithm was 10-15 % lower than that by the pencil-beam algorithm [21, 22] . For accurate calculation of dose distributions at the lung-tumor interface, the Monte Carlo dose calculation is favorable.
To investigate the dose differences among the GTV, ITV, and PTV, we evaluated the 4D dose distribution in SBRT planning based on the isocenter dose prescription by the Monte Carlo dose calculation algorithm.
Materials and methods

Patients and image acquisition
4D CT scans were performed for 12 consecutive patients who had 14 tumors. Written informed consent was obtained from all patients. Each patient had a primary or metastatic lung tumor with a diameter of not greater than 4 cm. A helical CT scanner (SOMATOM Sensation Open; Siemens Medical Solutions, Erlangen, Germany) was used with the following parameters: 120 kVp; 80 mA; 0.5 s rotation time; 1.2 mm slice collimation; 500 mm field of view; and 512 9 512 matrix. Patients had a pressure sensor (AZ-733V, Anzai Medical, Tokyo, Japan) affixed to the abdomen, and they were placed in the supine position with their arms above the head in a body immobilization device (BodyFix Blue-BAG; Medical Intelligence, Schwabmuenchen, Germany). They were asked to breathe regularly and quietly before the 4D CT scan. The breathing signal was detected by the pressure sensor and transferred to Siemens Syngo software. Eight respiration CT-phase images were then reconstructed retrospectively with a slice thickness of 2 mm.
Field setup and dose prescription
4D CT images were imported into an iPlan 4.1.2 (Brain-LAB, Feldkirchen, Germany) treatment-planning system (TPS), and MIP and AIP images were created. The GTV was delineated on each phase image by use of the lung CT window setting by a single experienced physician. No additional margin was added to generate the clinical target volume. Also, the ITV was contoured manually on the MIP images in consideration of the tumor motion as assessed by X-ray fluoroscopy. The PTV was defined as the ITV with a 5-mm margin to account for setup uncertainty. The isocenter was set to the centroid position of the PTV. Six noncoplanar static 6-MV X-ray beams were selected for dose calculation. In accordance with the protocol of the JCOG 0403, the beam apertures were shaped into the PTV plus a 5-mm margin with a multileaf collimator to ensure that the dose extended to the periphery of the PTV. The prescription dose for SBRT was 48 Gy in 4 fractions at the isocenter.
Dose calculation algorithms
Dose distributions were calculated by use of the X-ray voxel Monte Carlo (XVMC) algorithm implemented in the iPlan TPS. The XVMC algorithm has been optimized for clinically used energies and is now available commercially for high-energy photon beams [8, [23] [24] [25] [26] . The XVMC dose calculation was performed with a grid size of 2 mm and a mean variance of 1 % [25, 26] .
Deformable image registration and dose accumulation
A B-spline-based DIR method implemented in the Insight Segmentation and Registration Toolkit was applied for calculation of the volumetric mapping among the 4D CT images [27, 28] . The algorithm uses a mesh of control points in the images to deform the underlying images, until a local maximum of the images' similarity measure is found. We adopted a multiresolution approach by defining a uniform four-by-four grid of the control points, followed by a uniform twenty-by-twenty grid. For the similarity measure, the sum of squared differences was used. We used the volumetric mappings to deform the dose distributions on each respiratory phase image onto a referencephase CT image [29] . In this study, the end-exhale (EE) phase was chosen as the reference phase. The accumulation of the deformed dose distributions with equal weighting for each phase provided the 4D dose distribution. We previously verified the geometric accuracy of our DIR method in eight patients by comparing the calculated results with actual 4D CT images by landmark analysis, in a way similar to that of Miyabe et al. [30] . The geometric accuracy was 1.9 ± 1.6 mm for all patients, which was consistent with the accuracy reported in a multi-institution study [31] . For all patients who participated in this study, an analysis of the subtraction images of the two registered images was also carried out. If two images are similar, no differences should be observed in the subtraction images.
Flampouri et al. [32] reported that at least three-phase accumulated doses were required for achieving a betterthan-3 % agreement with the ten-phase accumulated dose. On this basis, we calculated the dose distribution in the present study by transferring identical treatment plans to four respiratory phase images (EE, mid-inhale, end-inhale [EI], and mid-exhale phase).
Plan evaluation
The GTV dose was calculated with the 4D accumulated dose (4D dose), whereas the ITV and PTV doses were calculated with the AIP image (3D dose). The dose-volume histogram (DVH) and the homogeneity index (HI) of the target volume (GTV, ITV, and PTV) were also calculated. The D 99 and D 95 were defined as the least doses received by 99 and 95 % of the target volume, respectively. The HI was described by use of the ratio of D 1 to D 99 . The dose difference between the PTV and GTV over the GTV dose was evaluated, as was the dose difference between the ITV and GTV. For statistical analysis, differences were considered significant at p \ 0.01 by use of Student's t test.
Results
The GTV characteristics are summarized in Table 1 . Amplitude was defined as the distance between GTV centroid positions in the EE and EI phase images. The size of the GTV was measured in the EE phase image, which can be considered to contain fewer artifacts.
The accuracy of the DIR method was evaluated by use of the subtraction images. For the three cases of the GTV (Nos. 2, 10, and 12) showing the largest respiratory amplitude, Fig. 1 shows coronal views of (a-c) the EE phase images, (d-f) the EI phase images before the DIR, (g-i) the EI phase images after the DIR to the EE phase, (j-l) the subtraction images before the DIR, and (m-o) the subtraction images after the DIR to the EE phase. If two images were perfectly registered, uniform gray images would result. The white region corresponds to higher density at the EE phase, and the black region corresponds to higher density at the EI phase in the subtraction images. By use of the DIR, the tumors in the EI phase images were adequately mapped to the tumor positions in the EE phase images. Figure 2 shows the mean and standard deviation of D 99 , D 95 , D 1 , and HI for the GTV, ITV, and PTV for all GTV cases. The mean differences between the PTV and GTV for D 99 , D 95 , and D 1 were -9.1 % (range -13.4 to -4.0 %), -7.7 % (-13.3 to -2.5 %), and 0.7 % (-2.8 to 6.4 %). These differences were significant for D 99 (p \ 0.01) and D 95 (p \ 0.01). The mean differences between the ITV and GTV for D 99 , D 95 , and D 1 were -1.1 % (range -5.5 to 1.9 %), -1.1 % (-4.6 to 1.7 %), and -0.1 % (-2.4 to 1.0 %), respectively, with none of these differences being significant. The mean HI for the GTV, ITV, and PTV was 1.14, 1.15, and 1.26, respectively. In Fig. 3, D 99 for the ITV and PTV is plotted as a function of D 99 for the GTV for each patient with linear regression lines. The slope and intercept of the GTV line were one and zero, respectively. The linear regression line for the ITV was close to the GTV line, whereas that for the PTV was far from the GTV line. The reason for this is that the intercept of the linear regression line for the PTV was -13.7 points lower than that of the GTV line, whereas the slopes were almost equal to one. The correlation coefficient between the ITV and GTV was 0.94, and that between the PTV and GTV was 0.89. Figure 4 shows the (a) 3D and (b) 4D dose distribution for GTV No. 5, with a large difference between the GTV and PTV doses. The high-dose end of the DVHs for this case is shown in Fig. 5a . Figure 4 also shows the (c) 3D and (d) 4D dose distribution for GTV No. 9 with only a small difference. The high-dose end of the DVHs for this case is shown in Fig. 5b . As is clear from Fig. 4 , the 3D dose at the periphery of the PTV was less than the 4D dose at the GTV in both cases. Underdosing of the PTV was also displayed as a wider shoulder in the DVH in Fig. 5 . In contrast, the DVH for the ITV was similar to that for the GTV in case 2.
Discussion
This study demonstrated that, when the dose was prescribed at the isocenter in SBRT planning, the 3D dose to PTV differed significantly from the 4D dose to the GTV, especially at the periphery of the PTV. In contrast, no significant difference was seen between the ITV and GTV dose. These findings are similar to those of previous studies based on the peripheral dose prescription methods [14, 15] , and they suggest that the 3D dose evaluation based on the ITV is useful as an alternative for the 4D GTV dose. Figures 2 and 3 show the relationship between D 99 for the GTV and ITV. D 99 for the ITV was only 1 % lower than that for the GTV in average, and a statistically significant correlation between them was found. The comparability of the GTV and ITV dose enables us to estimate the 4D GTV dose from the 3D ITV dose within an accuracy of 1 %. For example, Shibamoto et al. showed reasonable local control and overall survival rates and acceptable toxicity in lung SBRT [13] . The isocenter was used for the dose prescription. In all patients, 95 % of the PTV received at least 80 % of the prescribed dose, and in all but 1 patient, 95 % of the ITV was covered with greater than or equal to 94 % of the prescribed dose. In this case, 95 % of the GTV was considered to receive greater than or equal to 94 % of the prescribed dose. Further investigation for the individual GTV dose and clinical outcomes would provide important information for the development of treatment strategies.
In this study, a 5-mm ITV-to-PTV margin and a 5-mm leaf margin were used [7] , whereas Guckenberger et al. [33] used no additional leaf margin. The strategy for no leaf margins at the PTV edge improves the dose fall-off outside the PTV, but increases the dose heterogeneity within the PTV. This resulted in a higher HI value for the PTV of 1.30 in their study than that in our study.
To ensure that dosages at the periphery of the PTV were calculated accurately, we used XVMC, a ''special-purpose'' Monte Carlo code that uses sophisticated efficiency improvement tools to reduce the calculation time, such as variance reduction and approximate efficiency-improving techniques. These techniques resulted in mild disagreement with the ''general-purpose'' Monte Carlo codes within the lungs [23] . However, recent studies have shown that the XVMC calculation agrees well with measurements and is Fig. 4 a 3D and b 4D figure online) helpful in ensuring the accuracy of estimation of the dose distribution [8, 17, 34] . In our institution, the XVMC has been commissioned with a grid size of 2 mm and a mean variance of 1 % to agree with measurement within 1.5 % in a homogeneous phantom, and within 3 % in an inhomogeneous phantom and near interfaces. These parameters were the same in this study. Therefore, the calculated dose distribution with the XVMC around the lung-tumor interfaces adequately predicted the measured dose distribution.
Several limitations of this study warrant mention. First, we have not performed a quantitative assessment of our DIR method for the data sets in this study. Instead, a quantitative assessment with a limited number of landmarks was performed by different data sets. For the current data sets, the qualitative assessment of the subtraction images was performed. With these assessments, we estimated that the registration error around the tumor was 2 mm for the current data sets. This error was consistent with the results reported in a multi-institutional study [31] , and was smaller than the average respiratory amplitude of 4.4 mm (ranging from 0.0 to 8.4 mm). Therefore, our DIR method was good enough for estimation of the respiratory motion among the 4D CT images.
On the other hand, a residual error still existed because the DIR method could not exactly simulate whole-organ deformation inside patients. In the region of a steep dose gradient, such as the lung-tumor interface, a large registration error could lead to underestimation of the GTV dose. In four of the 14 GTVs, the D 99 for the GTV was lower than that for the ITV (ranging from 0.1 to 1.5 %). This could be due to a registration error, as well as a random error by use of the Monte Carlo dose calculation. Extreme caution is required for assessment of the DIR method around the region of interest. Improvement of the dose calculation accuracy by tuning of the Monte Carlo parameters could resolve the question regarding dose variations.
Another limitation of our study was that we did not evaluate the doses to organs at risk. The scan range of the 4D CT was set around the target so that additional exposure to patients was avoided. Some researchers have shown that the use of 4D dose calculation techniques appears to have a negligible impact on doses to critical structures [14, 35] . These studies indicate the possibility of predicting doses for critical structures without the use of the 4D dose distribution.
Conclusion
In this study, we evaluated the 4D dose distribution of SBRT planning based on the isocenter dose prescription by the Monte Carlo dose calculation algorithm. Whereas there were several limitations associated with the 4D dose calculation, we confirmed that the 3D dose to the PTV differed significantly from the 4D dose to the GTV, especially at the periphery of the PTV. In contrast, no significant difference was seen between the ITV and GTV dose. Under conditions of a 5-mm PTV margin and a 5-mm leaf margin, the ITV dose has the potential to represent the GTV dose. 
